Navigation Links
Inspire's Phase 3 CF Trial, Using PARI's Nebulizer & Compressor, Shows Positive Top-Line Results
Date:6/12/2008

Track designation and orphan drug status in the United States by the FDA and orphan drug designation in Europe by the European Medicines Agency (EMEA).

About PARI Respiratory Equipment, Inc.

PARI is a leading worldwide developer and manufacturer of fast and efficient aerosol delivery systems for patients with asthma, chronic lung disease, and cystic fibrosis. PARI's worldwide vision is to improve the lives of those affected by respiratory diseases and those who care for them.

Maker of the world's leading breath-enhanced reusable nebulizer, the PARI LC PLUS, and the new PARI LC Sprint nebulizer line, PARI also manufactures the award-winning PARI TREK S compact compressor, Bubbles the Fish II aerosol mask, and durable PARI PRONEB Ultra II. PARI's Vortex anti-static valved holding chamber improves the aerosol deposition of metered dose inhalers (MDI's). PARI's North American headquarters is in Midlothian, VA with worldwide headquarters in Starnberg, Germany. Online at http://www.Pari.com

Additional information is available by contacting Ayars & Associates at 805-845-5682 or Ashley Weigand at 804-253-7274 x711.


'/>"/>
SOURCE PARI Respiratory Equipment, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients
2. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
3. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
4. Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
5. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
6. Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
7. Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
8. Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine
9. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
10. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
11. Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , NEW YORK, Nov. 20 ...rch report is available in its catalogue. ,, P...ive ,, http://www.reportlinker.com/p0164373/...html#utm_source=prnewswire&utm_medium=pr&u...ors are treated as an integral part of any researc...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 ...rch report is available in its catalogue. ,, M... ,, http://www.reportlinker.com/p0164242/Med...tml#utm_source=prnewswire&utm_medium=pr&ut...dhesives and sealants is gaining preeminence in me...
(Date:11/20/2009)..., , PLYMOUTH MEETING, Pa., Nov. 20 /PRNe... York Times article that questions why currently ...t some cancers are being ignored, ECRI Institute, ... a roadmap to the evidence on Finasteride for Pre..., The November 13, 2009, New York Times artic...
Breaking Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Wildfires set to increase 50 percent by 2050 9392 1Wildfires set to increase 50 percent by 2050 9392 2Older Diabetics Should Avoid Dementia Meds 52962 1Older Diabetics Should Avoid Dementia Meds 52962 2Valve Repair First in New England Done With Robotic Device 52959 1Valve Repair First in New England Done With Robotic Device 52959 2Valve Repair First in New England Done With Robotic Device 52959 3
... Suggesting Need for Improved HAE Screenin..., Pa., Nov. 12 ViroPharma Incorporated,(Nasdaq: ...om its ongoing,open-label study, showing that in t...fully treated all types of acute hereditary angioe...ate of analysis. Patients suffering,acute attacks ...
...q: VICL ) announced today that the company has co...of its therapeutic DNA vaccine designed to,prevent... immunosuppressed,stem cell transplant recipients....e first 33 transplant recipients in the recipient-...05) post-transplant enhancement of,CMV-specific T-...
Other Medicine Technology:ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 2ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 3ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 4ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 5ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema 6Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial 2Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial 3Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial 4
(Date:11/20/2009)...TON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST ...al Meeting of Shareholders will be held on Monday,...to consider approval of two special resolutions. T...orize the sale of all or substantially all of the ...ided for in the asset purchase agreement dated Nov...
(Date:11/20/2009)...SON, N.J., Nov. 20 Rates... have peaked in late October, but the pandemic flu...ss in all age groups, including the elderly, accor...ated (NYSE: DGX ), the world,s leading provider ...,, In its most recent Quest Diagnostics Health ...
(Date:11/20/2009)...S, Nov. 20 The followin...tor of the Nevada Health Care Association: ,, "... and thanks Senate Majority Leader Harry Reid for ...toward our goal of protecting every Nevada seniors... preserving the strength and viability of our stat...
(Date:11/20/2009)...gton) November 20, 2009Emergency medical service (...mated 350,000 cardiac arrests each year. Only 5 t...est survive. Better quality cardiopulmonary resus...rs may be associated with better patient outcome. ...e largest clinical research network to study preho...
(Date:11/20/2009)...remains high and is expected to continue, CDC says...-- Some areas of the United States are seeing decl...official said Friday, and while the disease remain... states reported last week. , "We are beginning... the country, but there is still a lot of influenz...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3
...R TO OFFER POLICIES TO COMBAT DISEASE, SHAPE HEALT...endelsohn, president of The University of Texas ...recommendations for advancing the fight against ca....C. , , (Logo: http://www.newscom.com/cgi-bin/...
...nt System(TM) is Central Portal for Lecture Archiv... , , EL SEGUNDO, Calif., Feb. 11 Accordent Techn...xas Health Sciences Center at Houston (UTHSC) has...lecture content to improve comprehension and expan...
... Nursetogether.com Partners With Tafford Uniforms ...Community , Orlando, FL (... of the world,s largest free, online communities f...r to serve as the exclusive NurseTogether.com onli...
...b. 11 The board of directors,of Hillenbrand, Inc....a newly,created board seat, effective immediately.... as a director," said Ray J.,Hillenbrand, chairman... of great character, and we believe he will play a...
...STER, Ill., Feb. 11 Hendrix College , a leading ... innovator in employer wellness programs, announce...ease prevention and health promotion programs at ...rograms including biometric screenings, health cou...
...anted "change" is coming to senior citizens and al...ing in the "stimulus" bill becomes law. Rationing...g the economy, but it was inserted into the bill b...us bill seeks to lay the foundation for rationing ...
Other Medicine News:Health News:National Press Club to Host 'NEWSMAKER' Media Briefing on Health Policy Recommendations With Dr. John Mendelsohn 2Health News:Accordent Delivers Medical Lecture Capture Platform for University of Texas Health Sciences Center 2Health News:Accordent Delivers Medical Lecture Capture Platform for University of Texas Health Sciences Center 3Health News:Nursetogether.com Partners With Tafford Uniforms 2Health News:Nursetogether.com Partners With Tafford Uniforms 3Health News:Hillenbrand Board of Directors Appoints Joe Loughrey as New Director 2Health News:EngagementHealth(R) Launches Comprehensive Wellness Program with Hendrix College - 96 Percent of Hendrix Faculty and Staff Volunteer to Participate 2Health News:EngagementHealth(R) Launches Comprehensive Wellness Program with Hendrix College - 96 Percent of Hendrix Faculty and Staff Volunteer to Participate 3Health News:Stealth Rationing of Medical Care Sneaks Into the 'Stimulus' Bill, Says the Association of American Physicians and Surgeons (AAPS) 2
Portex Lo-Profile™ Tracheostomy Tubes
Disposable Cannula Cuffless Tracheostomy Tubes
Tracheostomy Tube
Ballard Adult Trach Care T-Piece
Medicine Products: